News
Shares fell after Eli Lilly announced results of a new pill that could rival the weight-loss potential of the Danish giant’s ...
Eli Lilly is suing four telemedicine companies selling compounded versions of its blockbuster obesity drug Zepbound and its ...
Eli Lilly has filed a lawsuit against four telehealth platforms selling compounded versions of its blockbuster metabolic ...
Rather counterintuitively, following some promising news about a pipeline drug, one analyst tracking Eli Lilly (NYSE: LLY) ...
Pharmaceutical giant Eli Lilly represents a powerful player in healthcare, bolstering the bullish case. However, valuation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results